Extraction form for project: Screening for Glaucoma in Adults - 1 of 2

Design Details

1. Study design

Arms

Arm NameArm Description
A. Netarsudil 0.02% four times per day
B. Timolol 0.5% twice per day

Sample Characteristics

1. N
A. Netarsudil 0.02% four times per day
B. Timolol 0.5% twice per day
Total
2. Baseline population
A. Netarsudil 0.02% four times per day
B. Timolol 0.5% twice per day
Total

Outcomes

TypeDomainSpecific measurement (i.e., tool/definition/specific outcome)PopulationsTimepoints
CategoricalVision disorderMean decreases across time points, range
  • All Participants
  • end of study
ContinuousHarm/adverse eventWithdrawal due to adverse events
  • All Participants
  • end of study

Risk of Bias Assessment

1. Random assignment
2. Allocation concealed
3. Groups similar at baseline
4. Eligibility criteria specified
5. Blinding: outcome assessors or data analysts
6. Intention-to-treat analysis
7. Reporting of attrition, contamination, etc.
8. Differential loss to followup or overall high loss to followup
9. Appropriate analysis including cluster correlation
10. Funding source
11. Randomization adequate?
12. Allocation concealment adequate?
13. Groups similar at baseline?
14. Eligibility criteria specified?
15. Outcome assessors masked?
16. Care provider masked?
17. Patient masked?
18. Attrition and withdrawals reported?
19. Loss to followup differential/ high?
20. People analyzed in the groups in which they were randomized?
21. Quality

Results

Categorical


Vision disorder (Mean decreases across time points, range)

All Participants
Descriptive StatisticsBetween Arm Comparisons
A. Netarsudil 0.02% four times per dayB. Timolol 0.5% twice per day
end of study
Range
Odds Ratio (OR)
95% CI low (OR)
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
A. Netarsudil 0.02% four times per dayB. Timolol 0.5% twice per day

Continuous


Harm/adverse event (Withdrawal due to adverse events)

All Participants
Descriptive StatisticsBetween Arm Comparisons
A. Netarsudil 0.02% four times per dayB. Timolol 0.5% twice per day
vs.
end of study
Percentage
Relative risk (RR) (95% CI)
Within Arm ComparisonsNet Comparisons
A. Netarsudil 0.02% four times per dayB. Timolol 0.5% twice per day
vs.